
Sign up to save your podcasts
Or


Today on the Medscape Medical Minute: Tirzepatide may provide more clinical benefits than GLP-1 drugs do; cannabidiol use is more common in pregnant women than in nonpregnant women; and a nonstatin cholesterol-lowering drug is associated with lower liver cancer risk. https://www.medscape.com/viewarticle/989872
By MedscapeToday on the Medscape Medical Minute: Tirzepatide may provide more clinical benefits than GLP-1 drugs do; cannabidiol use is more common in pregnant women than in nonpregnant women; and a nonstatin cholesterol-lowering drug is associated with lower liver cancer risk. https://www.medscape.com/viewarticle/989872